SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: tonyt who wrote (23470)7/24/1998 10:09:00 AM
From: Machaon  Read Replies (4) | Respond to of 32384
 
<< Did you establish your trading position yesterday? >>

That's a stupid question, isn't it? Of course, when I consider the source, it doesn't surprise me. <g>

Do you have problems with reading comprehension? Even if I "answered" directly to your obnoxious questions about my personal trading decisions, I doubt if you could fully understand my answers, as is very evident by the fact that you are asking this question in the first place!

By the way, did you realize that LGND has 3 drugs and 2 partnerships in the Osteoporosis area?

- Droloxifene, with Pfizer. (Phase II/III)
- CP336,156 Estrogen Agonist with Pfizer. (Phase I/II)
- TSE424 Estrogen Agonist with AHP. (Preclinical)

Their deep pipeline is really impressive. I guess that is why you are always badmouthing LGND. <g>

See tonyt scratch his head and wonder what I am talking about. <g>

Regards, Bob